期刊文献+

肿瘤超声抗原疫苗联合低剂量环磷酰胺在小鼠体内抗肿瘤效应的研究 被引量:1

The anti-tumor effects of the sonicate vaccine combining low dose cyclophosphamide in mice
下载PDF
导出
摘要 目的探索肿瘤超声抗原疫苗联合低剂量环磷酰胺(CTX)的抗肿瘤效应。方法 C57BL/6雄性小鼠48只,随机分为PBS对照组、CTX组、FBL3超声抗原疫苗组、FBL3超声抗原疫苗联合CTX组。按程序免疫3次后,每组随机取4只小鼠,流式细胞术比较脾细胞中CD4+CD25+Treg及CD8+T细胞比例,MTT法比较脾细胞杀伤FBL3功能,各组其余小鼠接种FBL3肿瘤细胞,观察成瘤时间及肿块大小。结果超声抗原疫苗不能诱导CD8+T细胞比例升高(P>0.05);CTX可下调Treg细胞数量(P<0.05);疫苗和CTX均可提高脾细胞体外肿瘤杀伤率并能缩小肿块体积、延长小鼠成瘤时间,两者联合显示更强的抗肿瘤效应。结论肿瘤超声抗原疫苗联合小剂量CTX可能通过提高体液免疫或固有免疫发挥抗肿瘤效应。 To investigate the anti-tumor effects of the sonicate antigen of FBL3 combined with low-dose cyclophosphamide(CTX),48 male C57BL/6 mice were randomly divided into four groups:PBS control group,CTX group,FBL3 sonicate antigen vaccine group and FBL3 vaccine combining CTX group.After three times of immunization,4 mice were sacrificed in every group randomly,and their spleen cells were obtained for detecting the ratio of CD4+CD25+Treg cells and CD8+T cells to total lymphocytes by flow cytometry,and testing the cytotoxic activity of spleen cells to FBL3 by 3-2,5-diphenyl-tetrazolium bromide(MTT) test.The other mice in every group were injected subcutaneously with FBL3 cells,and the growth rate and volume of tumor were observed and recorded.The results showed sonicate antigen vaccine alone could not increase the CD8+T ratio,while CTX alone could reduce the number of Tregs;when the vaccine was used in combination with CTX,it can enhance the cytotoxicity of spleen cells and delay formation of tumor,showing better anti-tumor effects.In conclusion,the antitumor synergism of the tumor sonicate antigen vaccine and low dose CTX may be gained through increasing humoral immunity or inherent immunity.
出处 《免疫学杂志》 CAS CSCD 北大核心 2014年第10期874-877,共4页 Immunological Journal
基金 山西省科技攻关项目(20090311057-7) 山西医科大学创新基金(01200902)
关键词 超声抗原 环磷酰胺 调节性T细胞(CD4+CD25+Treg) 抗肿瘤 Sonicate antigen Cyclophosphamide Regulatory T cell Anti-tumor
  • 相关文献

参考文献8

  • 1Steinman RM. The dendritic cell system and its role in immunogenicity[J]. Annu Rev Immunol, 1991, 9: 271-296.
  • 2Ikeda N, Toida I, Iwasaki A, et al. Surface antigen expression on bladder tumor cells induced by bacillus Calmette-Guerin (BCG): a role of BCG internalization into tumor cells[J]. Int J Urol, 2002, 9(1): 29-35.
  • 3Liyanage UK, Moore TF, Joo HG, et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma[J]. J Immunol, 2002, 169(5): 2756-2761.
  • 4Hoffmann C, Stanke J, Kaufmann AM, et al. Combining T- cell vaccination and application of agonistic anti-GITR mAb (DTA-1) induces complete eradication of HPV oncogene expressing tumors in mice[J]. J Immunother, 2010, 33(2): 136-145.
  • 5Mitsui J, Nishikawa H, Muraoka D, et al. Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signals[J]. Clin Cancer Res, 2010, 16(10): 2781-2791.
  • 6Motoyoshi Y, Kminoda K, Saitoh O, et al. Different mechanisms for anti-tumor effects of low- and high-dose cyclophosphamide[J]. Oncol Rep, 2006, 16(1): 141-146.
  • 7苑晓娟,樊卫平,张凯,刘玲玲,彭霞,谢艳云.小剂量环磷酰胺对正常小鼠CD4^+CD25^+Treg细胞的调节作用[J].免疫学杂志,2011,27(4):292-296. 被引量:6
  • 8龚非力,熊思东,李卓娅,等.医学免疫学[M].3版.北京:科学出版社,2012:70-80.

二级参考文献15

  • 1甘长清,王小毅.CD4^+CD25^+调节性T细胞和Foxp3在不同病理类型乳腺癌患者外周血和组织中表达水平及其临床意义[J].免疫学杂志,2009,25(3):322-325. 被引量:9
  • 2赵弋清,罗霞,陈东辉,余梦瑶,杨志荣.不同剂量环磷酰胺诱导正常小鼠免疫抑制的对比研究[J].免疫学杂志,2005,21(B06):122-124. 被引量:82
  • 3Sakaguchi S, Saka guchi N, Asano M. et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 recept or alpha-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[J].J Immunol, 1995, 155(3):1151-1164.
  • 4Liyanage UK, Moore TT, Joo HG, et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma [J]. J Immunol, 2002, 169(5):2756-2761.
  • 5Ghiringheli F, l,armonier N, Schmitt E, el al. CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative [J]. Eur J Immunol, 2004, 34(2): 336-344.
  • 6Sutmuller RP, van Duivenvoorde LM, van Elsas A, et al. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses [J]. J Exp Med, 2001, 194(6):823-832.
  • 7Ikezawa Y, Nakazawa M, Tamura C, et al. Cyclophosphamide decreases the number, percentage and the function of CD25+CD4+regulatory T cells, which suppress induction of contact hypersensitivity [J]. J Dermatol Sci, 2005, 39 (2): 105-112.
  • 8Motoyoshi Y, Kminoda K, Saitoh O, et al. Different mechanisms for anti-tumor effects of low- and high-dose cyclophosphamide [J]. Oncol Rep, 2006,16(1):141-146.
  • 9Liu JY, Wu Y, Zhang XS, et al. Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine [J]. Cancer Immunol Immunother, 2007, 56(10): 1597-1604.
  • 10Di Paolo NC, Tuve S, Ni S, et al. Effect of adenovirus mediated heat shock protein expression and oncolysis in combination with low-dose cyclophosphamide treatment on anti-tumor immune responses [J]. Cancer Res, 2006, 66 (2): 960-969.

共引文献8

同被引文献8

  • 1Nie H, Neerincx PB, van der Poel J, et al. Microarray datamining using bioconductor packages[J]. BMC Proc, 2009,3 (Suppl 4): S9.
  • 2Makita M,Hiraki A, Azuma T, et al. Antilung cancer effectof WT1-specific cytotoxic T lymphocytes [J]. Clin CancerRes, 2002,8(8): 2626-2631.
  • 3Doubrovina ES, Doubrovin MM, Lee S,et al. In vitrostimulation with WT1 peptide-loaded Epstein-Barr virus-positive B cells elicits high frequencies of WT1 peptide -specific T cells with in vitro and in vivo tumoricidalactivityfj]. Clin Cancer Res, 2004, 10(21): 7207-7219.
  • 4Shirakata T, Oka Y,Nishida S, et al. WT1 peptide therapyfor a patient with chemotherapy -resistant salivary glandcancerfj]. Anticancer Res, 2012, 32(3): 1081-1085.
  • 5Oka Y, Tsuboi A, Taguohi T, et al. Induction of WT1(Wilms,tumor gene)-specific cytotoxic T lymphocytes byWT1 peptide vaccine and the resultant cancer regressionfj].Proc Nati Acad Sci USA, 2004, 101(38): 13885-13890.
  • 6Bellantuono I,Gao L, Parry S, et al. Two distinct HLA-A0201 -presented epitopes of the Wilms tumor antigen 1can function as targets for leukemia-reactive CTL[J]. Blood,2002,100(10): 3835-3857.
  • 7Oka Y, Udaka K, Tsuboi A, et al. Cancer immunotherapytargeting Wilms ’ tumor gene WT1 product[J]. J Immunol,2000, 164(4): 1873-1880.
  • 8樊卫平,谢艳云,宋玉靖,王宏伟,郝彦琴,苑晓娟.WT1-235肽体外抗肿瘤效应的研究[J].免疫学杂志,2011,27(5):377-380. 被引量:3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部